Loading chart…
LIVE
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups.
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The JAGSNPHARM share price is ₹217.39 (-1.14% today), with a market capitalisation of ₹14B and a price-to-earnings (P/E) ratio of 32.6. MarketRipple tracks the JAGSNPHARM investment thesis, the ripple-chain impact of market events on Jagsonpal Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹215.90
High
₹218.00
Low
₹215.00
Prev. Close
₹219.89
52W High
₹264.50
52W Low
₹155.00
Day range
₹215.00–₹218.00
52-week range
₹155.00–₹264.50
Volume
6K
P/E
32.6
ROE
18.2%
D/E
0.03
Margin
14.3%
Jagsonpal Pharmaceuticals Limited (NSE: JAGSNPHARM) is currently trading at ₹217.39 (-1.14%).
Jagsonpal Pharmaceuticals Limited's market capitalization is ₹14B.
Jagsonpal Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 32.6.
Jagsonpal Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).